help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pati, D.
Right arrow Articles by Habibi, H. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pati, D.
Right arrow Articles by Habibi, H. R.

Endocrinology, Vol 136, 75-84, Copyright © 1995 by Endocrine Society


ARTICLES

Inhibition of human hepatocarcinoma cell proliferation by mammalian and fish gonadotropin-releasing hormones

D Pati and HR Habibi
Department of Biological Sciences, University of Calgary, Alberta, Canada.

This study provides the first demonstration that human hepatocarcinoma- derived cell line HepG2 contains GnRH receptors and responds to various molecular forms of GnRH in terms of inhibition of proliferation in a time- and dose-related manner. In addition, GnRH peptides also significantly inhibited the uptake of [3H]thymidine by these cells. The effect of GnRH was specific because GnRH antagonists reversed the GnRH- mediated inhibition, and non-GnRH peptides had no effect on HepG2 cell proliferation. An important finding is that certain fish GnRH molecules such as lamprey GnRH, which has little gonadotropin (LH) release activity in mammals, suppress hepatocarcinoma cell proliferation with similar potency to a superactive mammalian GnRH analog, [D-Lys6]GnRH. These findings may have profound implications in the development of an effective chemotherapy for treatment of human liver cancer. An added advantage is that fish GnRH forms will likely exert little side effect in terms of human pituitary gonadotropin release, gonadal steroidogenesis, and reproductive functions in general.


This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. Mancinelli, P. Onori, E. Gaudio, S. DeMorrow, A. Franchitto, H. Francis, S. Glaser, G. Carpino, J. Venter, D. Alvaro, et al.
Follicle-stimulating hormone increases cholangiocyte proliferation by an autocrine mechanism via cAMP-dependent phosphorylation of ERK1/2 and Elk-1
Am J Physiol Gastrointest Liver Physiol, July 1, 2009; 297(1): G11 - G26.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Morgan, A. J. Stewart, N. Miller, P. Mullen, M. Muir, M. Dodds, F. Medda, D. Harrison, S. Langdon, and R. P. Millar
Gonadotropin-Releasing Hormone Receptor Levels and Cell Context Affect Tumor Cell Responses to Agonist In vitro and In vivo
Cancer Res., August 1, 2008; 68(15): 6331 - 6340.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
A. C Wilson, M S. Salamat, R. J Haasl, K. M Roche, A. Karande, S. V. Meethal, E. Terasawa, R. L Bowen, and C. S Atwood
Human neurons express type I GnRH receptor and respond to GnRH I by increasing luteinizing hormone expression
J. Endocrinol., December 1, 2006; 191(3): 651 - 663.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. Nagy and A. V. Schally
Targeting of Cytotoxic Luteinizing Hormone-Releasing Hormone Analogs to Breast, Ovarian, Endometrial, and Prostate Cancers
Biol Reprod, November 1, 2005; 73(5): 851 - 859.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. Keller, A. V. Schally, T. Gaiser, A. Nagy, B. Baker, G. Halmos, and J. B. Engel
Receptors for Luteinizing Hormone Releasing Hormone Expressed on Human Renal Cell Carcinomas Can Be Used for Targeted Chemotherapy with Cytotoxic Luteinizing Hormone Releasing Hormone Analogues
Clin. Cancer Res., August 1, 2005; 11(15): 5549 - 5557.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Keller, A. V. Schally, T. Gaiser, A. Nagy, B. Baker, G. Westphal, G. Halmos, and J. B. Engel
Human Malignant Melanomas Express Receptors for Luteinizing Hormone Releasing Hormone Allowing Targeted Therapy with Cytotoxic Luteinizing Hormone Releasing Hormone Analogue
Cancer Res., July 1, 2005; 65(13): 5857 - 5863.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
T.A. Bramley, H.P. Boyle, and G.S. Menzies
Human placental GnRH-like factors: parallel displacement in GnRH immuno- and receptor-binding assays can be caused by degradation of radiolabelled GnRH tracers
Mol. Hum. Reprod., December 1, 1999; 5(12): 1095 - 1106.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Pati and H. R. Habibi
Presence of Salmon Gonadotropin-Releasing Hormone (GnRH) and Compounds with GnRH-Like Activity in the Ovary of Goldfish
Endocrinology, April 1, 1998; 139(4): 2015 - 2024.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Nechushtan, S. Yarkoni, I. Marianovsky, and H. Lorberboum-Galski
Adenocarcinoma Cells Are Targeted by the New GnRH-PE66 Chimeric Toxin through Specific Gonadotropin-releasing Hormone Binding Sites
J. Biol. Chem., April 25, 1997; 272(17): 11597 - 11603.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society